Is it a Good Decision to Add Regeneron Pharmaceuticals (REGN) to Your Portfolio?
Investment management company RGA Investment Advisors recently released its third-quarter 2022 investor letter. A copy of the same can be downloaded here.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
News
- First
- << Previous
- 61 - 70
- Next >>
10 Best Pharmaceutical Stocks to Buy According to Steven Boyd's Armistice Capital
In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd's Armistice Capital.
Top 5 Stock Picks of John Hempton's Bronte Capital
In this article, we discuss the top 5 stock picks of John Hempton's Bronte Capital.
Top 5 Trending Stocks on Friday
Shares of Zscaler, Inc. (NASDAQ:ZS) jumped nearly 15 percent in pre-market trading Friday after delivering impressive financial results for its fiscal fourth quarter.
25 Biggest Pharmaceutical Companies in the World A Year Ago
In this article we listed the 25 biggest pharmaceutical companies in the world a year ago and then compared their market caps today.
20 Most Expensive Stocks In the US
Regardless of whether you're a day trader or a long term investor, the 20 most expensive stocks in the US will cause a double-take! No matter what one's situation is, or what the economy's situation ...
10 Healthcare Stocks to Watch Amid Senate’s Healthcare Bill
In this article, we will be taking a look at 10 healthcare stocks to watch amid Senate's healthcare bill.
Top 5 Gainers on Wednesday
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) rose over six percent after the opening bell this morning.
10 Most Profitable Biotech Companies in the World
In this article, we discuss the 10 most profitable biotech companies in the world.
5 Biotech Stocks to Buy According to Billionaire David E. Shaw
In this piece, we will take a look at five biotechnology stocks to buy according to billionaire David E. Shaw.
- First
- << Previous
- 61 - 70
- Next >>
Billionaire Hedge Funds
